Washington Trust Advisors’s Cerence CRNC Stock Holding History

Washington Trust Advisors’s Portfolio CRNC Stock Details CRNC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-629	Closed	-$48K	–	999
2021 Q4	$48K	Buy	+629	New	+$55.5K	﹤0.01%	483

Other funds holding CRNC

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

VVP

Vulcan Value Partners Birmingham, Alabama $3.77B AUM 9.63% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

GKIM

GW&K Investment Management Boston, Massachusetts $11.3B AUM 31.98% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

VBA

Van Berkom & Associates Montreal, Quebec, Canada $3.08B AUM 12.07% 1-Year Est. Return

Washington Trust Advisors's CRNC Position: Q1 2022 in Review

Washington Trust Advisors sold out of Cerence (CRNC) in Q1 2022, closing a stake of 629 shares — an estimated $48K sold.

Washington Trust Advisors first reported a position in CRNC in Q4 2021 and held it in 1 quarter. The position peaked at $48K in Q4 2021. 286 funds tracked by Wall St. Rank hold CRNC as of Q1 2022.

Washington Trust Advisors reported no remaining Cerence position as of Q1 2022 after selling out during the quarter.
Washington Trust Advisors sold 629 Cerence shares in Q1 2022, an estimated $48K.
Washington Trust Advisors first reported a position in Cerence in Q4 2021 and held it in 1 quarter.
Washington Trust Advisors's Cerence position peaked at $48K in Q4 2021.
286 funds tracked by Wall St. Rank held Cerence as of Q1 2022.

Based on Washington Trust Advisors's 13F filing for Q1 2022, filed 5 May 2022.